[Diabetic retinopathy risk factors]
- PMID: 18506268
- DOI: 10.1590/s0004-27302008000300003
[Diabetic retinopathy risk factors]
Abstract
Diabetic retinopathy (DR) occurs in about 95% of patients with type 1 diabetes mellitus (DM) and in 60% of type 2 DM patients and it is the main cause of legal blindness in adult people. The aim of this manuscript was to review the main risk factors for DR. The major environmental risk factors are hyperglycemia, high blood pressure levels, and long-term duration of DM. However, not all patients will not develop DR, suggesting the presence of a genetic predisposition to DR, especially for severe forms of DR. Special strategies has been used to evaluate the genetic role in DR. Family studies shown that there is a familial aggregation of DR. Candidates genes have been studied (RAGE; VEGF; PPAR-delta; ICAM-1; ECA; ENPP 1; eNOS) and positive or negative associations with DR were demonstrated. Some chromosomes were also associated to DR in selected populations. Finally, genetic expression studies reinforce the association of candidate genes, or participation of others genes, with the presence of DR. DR is a common complication of DM and, along with non-genetic or environmental risk factors, the identification of genes related to DR could result in more specific and efficient DR treatment.
Similar articles
-
Candidate gene studies of diabetic retinopathy in human.Mol Biol Rep. 2016 Dec;43(12):1327-1345. doi: 10.1007/s11033-016-4075-y. Epub 2016 Oct 11. Mol Biol Rep. 2016. PMID: 27730450 Free PMC article. Review.
-
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.J Diabetes Complications. 2017 Aug;31(8):1348-1353. doi: 10.1016/j.jdiacomp.2017.04.010. Epub 2017 Apr 13. J Diabetes Complications. 2017. PMID: 28551296
-
Risk factors associated with diabetic retinopathy among type 2 diabetes patients at teaching hospital in Malaysia.Diabetes Metab Syndr. 2015 Apr-Jun;9(2):98-103. doi: 10.1016/j.dsx.2014.04.019. Epub 2014 Jun 4. Diabetes Metab Syndr. 2015. PMID: 25470640
-
[Diabetic retinopathy: pathogenesis and therapeutic implications].Vnitr Lek. 2016 Fall;62(7-8):620-8. Vnitr Lek. 2016. PMID: 27627088 Review. Czech.
-
Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus.Rev Assoc Med Bras (1992). 2009 May-Jun;55(3):268-73. doi: 10.1590/s0104-42302009000300017. Rev Assoc Med Bras (1992). 2009. PMID: 19629344
Cited by
-
Bone Marrow-Derived Mesenchymal Stem Cells Restored High-Fat-Fed Induced Hyperinsulinemia in Rats at Early Stage of Type 2 Diabetes Mellitus.Cell Transplant. 2020 Jan-Dec;29:963689720904628. doi: 10.1177/0963689720904628. Cell Transplant. 2020. PMID: 32228047 Free PMC article.
-
Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population.Exp Diabetes Res. 2012;2012:350852. doi: 10.1155/2012/350852. Epub 2012 Oct 14. Exp Diabetes Res. 2012. PMID: 23304115 Free PMC article.
-
High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with proliferative diabetic retinopathy.PLoS One. 2015 Mar 30;10(3):e0122022. doi: 10.1371/journal.pone.0122022. eCollection 2015. PLoS One. 2015. PMID: 25822410 Free PMC article.
-
Serum Iron and Risk of Diabetic Retinopathy.Nutrients. 2020 Jul 31;12(8):2297. doi: 10.3390/nu12082297. Nutrients. 2020. PMID: 32751778 Free PMC article.
-
Diabetic retinopathy screening using artificial intelligence and its predictors among people with type 2 diabetes mellitus in an urban area of Durgapur.J Family Med Prim Care. 2025 May;14(5):1871-1877. doi: 10.4103/jfmpc.jfmpc_1693_24. Epub 2025 May 31. J Family Med Prim Care. 2025. PMID: 40547758 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous